DK2577A - Fremgangsmade til fremstilling af prostaglandinanaloge - Google Patents

Fremgangsmade til fremstilling af prostaglandinanaloge

Info

Publication number
DK2577A
DK2577A DK2577A DK2577A DK2577A DK 2577 A DK2577 A DK 2577A DK 2577 A DK2577 A DK 2577A DK 2577 A DK2577 A DK 2577A DK 2577 A DK2577 A DK 2577A
Authority
DK
Denmark
Prior art keywords
innalogue
prostagland
procedure
prostagland innalogue
innalogue procedure
Prior art date
Application number
DK2577A
Other languages
English (en)
Other versions
DK146025C (da
DK146025B (da
Inventor
M Hayashi
S Kori
H Wakatsuka
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/646,316 external-priority patent/US4052512A/en
Priority claimed from GB1598276A external-priority patent/GB1540427A/en
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of DK2577A publication Critical patent/DK2577A/da
Priority to DK255780A priority Critical patent/DK146202C/da
Publication of DK146025B publication Critical patent/DK146025B/da
Application granted granted Critical
Publication of DK146025C publication Critical patent/DK146025C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00Compounds containing selenium
    • C07C391/02Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/02Lithium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK2577A 1976-01-05 1977-01-04 Analogifremgangsmaade til fremstilling af trans-delta2-prostaglandinanaloge DK146025C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK255780A DK146202C (da) 1976-01-05 1980-06-13 Trans-delta2-prostaglandinanaloge og materiale indeholdende disse til brug som antifertilitetsmidler og andre ikke-medicinske formaal

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US05/646,316 US4052512A (en) 1976-01-05 1976-01-05 Prostaglandin analogues
US64631676 1976-01-05
GB1598276A GB1540427A (en) 1972-12-29 1976-04-20 Prostaglandin analogues
GB1598276 1976-04-20

Publications (3)

Publication Number Publication Date
DK2577A true DK2577A (da) 1977-07-06
DK146025B DK146025B (da) 1983-05-30
DK146025C DK146025C (da) 1983-10-24

Family

ID=26251676

Family Applications (1)

Application Number Title Priority Date Filing Date
DK2577A DK146025C (da) 1976-01-05 1977-01-04 Analogifremgangsmaade til fremstilling af trans-delta2-prostaglandinanaloge

Country Status (6)

Country Link
JP (1) JPS5285151A (da)
AU (1) AU512644B2 (da)
DK (1) DK146025C (da)
IE (1) IE45491B1 (da)
LU (1) LU76513A1 (da)
NZ (1) NZ182968A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017195762A1 (ja) 2016-05-09 2017-11-16 旭硝子株式会社 新規なプロスタグランジン誘導体
CA3079807A1 (en) 2017-10-31 2019-05-09 AGC Inc. Method for producing prostaglandin derivative

Also Published As

Publication number Publication date
NZ182968A (en) 1978-12-18
AU512644B2 (en) 1980-10-23
IE45491L (en) 1977-07-05
JPS5285151A (en) 1977-07-15
IE45491B1 (en) 1982-09-08
LU76513A1 (da) 1977-07-14
JPS5761276B2 (da) 1982-12-23
AU2104477A (en) 1978-07-13
DK146025C (da) 1983-10-24
DK146025B (da) 1983-05-30

Similar Documents

Publication Publication Date Title
DK13177A (da) Fremgangsmade til fremstilling af phthalaner
DK116177A (da) Fremgangsmade til fremstilling af hentriakontapeptider
DK81277A (da) Fremgangsmade til fremstilling af bis-pyridinium-forbindelser
DK323677A (da) Fremgangsmade til fremstilling af androstan-17-on-derivater
DK147777A (da) Fremgangsmade til fremstilling af acylchromaner
DK144177A (da) Fremgangsmade til fremstilling af acylayanider
DK153483C (da) Fremgangsmaade til fremstilling af gamma-pyroner
DK145877A (da) Fremgangsmade til immoblisering af glucoseisomerase
DK229877A (da) Fremgangsmade til bestemmelse af barbiturater
DK123277A (da) Fremgangsmade til fremstilling af 3-halogenmethyl-3-cephem-forbindelser
DK31977A (da) Fremgangsmade til fremstilling af chromanderivater
DK318876A (da) Fremgangsmade til fremstilling af prostaglandinanaloge
DK65877A (da) Fremgangsmaade til fremstilling af mikrokapsler
DK310777A (da) Fremgangsmade til fremstilling af guaiacol-p-isobutyl-hydratropat
DK435876A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK435776A (da) Fremgangsmade til fremstilling af phosphitchlorider
DK420477A (da) Spaerreorgan til moentkanal
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK428377A (da) Fremgangsmaade til fremstilling af pyridobenzodiazepinoner
DK73977A (da) Fremgangsmade til fremstilling af d-homosteroider
DK263577A (da) Fremgangsmade til fremstilling af substituerede 2-v-nyl-chromoner
SE7701143L (sv) Polumerisatinosforfarande
DK88677A (da) Fremgangsmade til fremstilling af substituerede puriner
DK126577A (da) Fremgangsmade til fremstilling af n-propargylpiperonylamin
DK184277A (da) Fremgangsmade til dekoffeinering

Legal Events

Date Code Title Description
PUP Patent expired